West Pharmaceutical Services (WST)
West Pharmaceutical Services Revenues: 316.30M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
WST Revenues Rankings
| Overall | 67th percentile | 1441 of 4431 |
| Sector | 79th percentile | 98 of 471 in Healthcare |
| Industry | 79th percentile | 14 of 68 in Medical Instruments & Supplies |
WST Revenues Range, Past 5 Years
| Minimum | 242.40M | Mar 2009 |
| Maximum | 316.30M | Mar 2012 |
| Average | 274.13M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these WST related companies
WST News
$WST New 52 Week High - Crossed daily highs resistance. Next resistance 47.96 from 4/29/2011.
about 3 days ago by TradeIdeasQuant
about 3 days ago by TradeIdeasQuant
Listen to $WST Q1 2012 earnings call - live at 09:00 AM, ondemand after - http://stks.co/3WZd
about 36 days ago by earningscast
about 36 days ago by earningscast
West Pharmaceutical Services, Inc. (WST) Tops Q1 EPS by 16c; Raises FY Guidance
Apr 26, 7:27AM Street Insider
Apr 26, 7:27AM Street Insider
11 breakouts: $TISA, $WST (gap); three sub-$1 and two $1-2. For a day markets closed up over 1% the breakout list is relatively barren
about 45 days ago by fallondpicks
about 45 days ago by fallondpicks
News related to $WST, currently +4.3% since open: 'West Pharma Services rises on improved outlooks' http://stks.co/3Nej
about 45 days ago by TradeBot
about 45 days ago by TradeBot
$WST is 5.1% up since open on unusual high volume and 10.6% up since close.
about 45 days ago by TradeBot
about 45 days ago by TradeBot
West Pharma (WST) Reports Preliminary Q1 EPS of 88c, Tops Views; Boosts FY12 EPS Outlook
Apr 17, 7:13AM Street Insider
Apr 17, 7:13AM Street Insider
2 Ex-Dividend Stocks With Buy Ratings http://stks.co/3Kq5 My story via @TheStreet $VALE $WST #Dividend #ExDividend
about 49 days ago by azendrian
about 49 days ago by azendrian
$WST filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/2yoi
about 72 days ago by MarketBrief
about 72 days ago by MarketBrief
Listen to $WST Q4 2011 earnings call (EPS 0.59 vs est 0.55) - live at 09:00 AM, ondemand after - http://stks.co/2RHl
about 106 days ago by earningscast
about 106 days ago by earningscast
Stocks trading ex-dividend one week from today: http://stks.co/1ntB / $ALG $BDGE $EPIQ $WSCI $WST
about 147 days ago by DynamicDividend
about 147 days ago by DynamicDividend
These Companies Will Raise Their Dividends in October (updated w/ results): http://stks.co/lXd / $BRO $EV $NWN $RPM $SCL $VFC $WST
about 221 days ago by DynamicDividend
about 221 days ago by DynamicDividend
Ex-Dividend Stocks for Monday 10/17: http://stks.co/YQ5 / $LEN $LOW $PNC $SUNS + Raised divs from $SNH $WST + Big special div from $VALE
about 235 days ago by DynamicDividend
about 235 days ago by DynamicDividend
West Pharmaceutical raises dividend for 19th consecutive year: http://stks.co/Xe3 / $WST yields 1.94%
about 238 days ago by DynamicDividend
about 238 days ago by DynamicDividend
These Companies Will Raise Their Dividends in October: http://stks.co/RMN / $BRO $EV $NWN $RPM $SCL $VFC $WST
about 245 days ago by DynamicDividend
about 245 days ago by DynamicDividend
West Pharma Services Reports EPS of $0.60 vs. $0.62 Estimate; Revenues $295.4M vs. $291.97M Estimate $WST
about 400 days ago by Benzinga
about 400 days ago by Benzinga
Ex-Dividend Stocks for Monday, April 18: http://goo.gl/eziPt / $HNP $LOW $PVX $SHLM $TI $WST
about 417 days ago by DynamicDividend
about 417 days ago by DynamicDividend
$WST http://chart.ly/n8g36jh WST - 17 new highs and up 78.86% in the last month - http://www.barchart.com/quotes/stocks/WST
about 424 days ago by jimvanmeerten
about 424 days ago by jimvanmeerten
$WST http://chart.ly/8obcwoh WST - 17 new highs and up 78.86% in the last month - http://www.barchart.com/quotes/stocks/WST
about 424 days ago by jimvanmeerten
about 424 days ago by jimvanmeerten
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| WST | 47.80 | -0.05 | -0.10% | 1.615B |
| WSBC | 20.33 | +0.08 | +0.40% | 541.39M |
| WSB | 2.700 | -0.14 | -4.93% | 21.57M |
| WRN | 0.84 | -0.04 | -4.55% | 78.36M |
| WRLS | 7.50 | +0.29 | +4.02% | 123.98M |
| WRLD | 68.44 | +0.05 | +0.07% | 1.018B |
| WRI | 25.58 | +0.28 | +1.11% | 3.091B |
| WRES | 2.15 | -0.02 | -0.92% | 153.77M |
| WREI | 34.72 | +0.44 | +1.27% | |
| WRE | 28.14 | +0.15 | +0.54% | 1.865B |
